Platelet–lymphocyte ratio is an independent prognostic factor in patients with ALK -positive non-small-cell lung cancer

Authors:

Abstract
Aim: As the prognostic value of the neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) is unclear in patients with ALK-positive non-small-cell lung cancer (NSCLC), this study assessed the importance of these factors was in this patient subset. Patients & methods: In 173 patients with primary ALK-positive NSCLC at pathological stages I–IV, neutrophil, platelet, lymphocyte, D-dimer and eosinophil levels were recorded before starting treatment. Results: The patients’ median NLR and PLR values were 2.10 and 127.69, respectively. Univariate analyses showed that NLR and PLR values, the D-dimer level and the eosinophil count were all associated with survival. Although multivariate analysis showed PLR to be an independent prognostic factor for overall survival (p = 0.018), NLR was not. Conclusion: PLR is an independent prognostic factor in ALK-positive NSCLC.
Funding Information
  • Pfizer

This publication has 25 references indexed in Scilit: